· Ferncliff Listed Dai AS, 270,000,000 shares representing 19.49% of the issued shares and votes in Bionor following completion of the rights issue
· Datum AS, 90,879,310 shares representing 6.56 % of the issued shares and votes in Bionor following completion of the rights issue
· Cipriano AS, 50,000,000 shares representing 3.61 % of the issued shares and votes in Bionor following completion of the rights issue
Ferncliff Listed Dai AS is controlled by Øystein Stray Spetalen and Cipriano AS is controlled by Einar J. Greve.
None of the shareholders above or their respective related persons hold any other shares or rights to shares in Bionor.
This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bionor Pharma ASA via GlobeNewswire
Last updated on: 06/10/2016